Cosmetic Intolerance and Patch Tests in 132 Opera-House Artistes
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact paper measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 116 singers and dancers plus 16 make-up artists from an opera house. |
| Design | Cross-sectional interviews, examinations and patch testing with a standard series and opera-house materials. |
| Comparator | Observed reactions were contextualized against dermatitis-patient frequencies; there was no concurrently recruited external control group. |
| Timepoint | Single study assessment. |
| Key result | Common lesions occurred in about one-third, more than half reported cosmetic intolerance, and only three had positive colophony patch tests; fragrance-mix and balsam-of-Peru positivity resembled dermatitis-patient patterns. |
| Funding/conflict context | Indexed as non-U.S. government research support; author conflicts were not stated in the PubMed abstract. |
What was actually measured?
Common lesions occurred in about one-third, more than half reported cosmetic intolerance, and only three had positive colophony patch tests; fragrance-mix and balsam-of-Peru positivity resembled dermatitis-patient patterns.
The authors' null-leaning conclusion is important: colophony allergy did not appear to be a major cosmetics problem in this setting despite frequent reported intolerance.
The denominator defines the claim. A diagnostic case, a patch-test reaction, a material analysis and a population rate answer different questions. None should be silently converted into another.
What the result does not prove
Self-report, a single workplace and indirect historical comparison limit causal interpretation; exact confidence intervals were not provided in the abstract.
Temporal or anatomic alignment can strengthen an exposure hypothesis, but it does not automatically prove individual causation. Referral patterns, prior sensitization, friction, sweat, occlusion, cleaning products, adhesives, metals, rubber additives and equipment age may all shape the finding.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the paper’s conclusions, this interpretation or any product.
Keep the condition categories separate
Dryness, friction injury, irritant dermatitis, allergic contact dermatitis, infection and swelling are not interchangeable. Patch testing evaluates delayed contact allergy; it does not diagnose every rash or replace clinician judgment.
Rapid facial or throat swelling, breathing difficulty, spreading redness, drainage, fever, severe pain, widespread blistering or loss of function requires prompt medical assessment. Do not deliberately re-expose yourself to suspected equipment or chemicals.
Activity and exposure details worth documenting
- Exact equipment, surface, material, adhesive, cleaner, glove, shoe, strap or instrument touching the area.
- Location and shape of the skin change relative to the contact site.
- Time from exposure to symptoms, and what changed during rest or avoidance.
- Sweat, friction, pressure, wetness, occlusion, ultraviolet exposure and cleaning routines.
- Manufacturer material disclosures, workplace safety data and clinician-directed testing—not self-testing.
Prevention comes before cosmetic care
Prevention must match the hazard: fit and friction control, material substitution, protective equipment, engineering controls, occupational-health review and clinician-guided allergen avoidance. Never apply workplace or sports chemicals directly to skin to “test” them.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 7634780
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: contact dermatitis
- American Academy of Dermatology: dry-skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This paper did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, allergy, infection, blisters or swelling; relieves pain or itch; neutralizes an allergen; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Personal UV Dose in 10 Young Skiers
- UV-Prevention Practices Reported by 1,200 Outdoor-Sport Coaches
- Occupational Allergy to a PVC Table Cover Used as a Mouse Pad
- Leather Chromium and Cobalt Traced in One Lineman and Cowboy
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation, product-safety determination or occupational clearance.